Berlin, GERMANY (March 2016) – Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration (FDA) 510k clearance for its brain navigation software.
Berlin, GERMANY (March 22, 2016) – Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration (FDA) clearance for new ENT instruments.
Berlin (March 17, 2016) – Fiagon AG, a manufacturer of clinical navigation systems, today announced it has increased its investment budget by 7.5 million euros with the support of Donghai Securities (Donghai), one of China’s most successful investment banks, and the German Startups Group, an investment company headquartered in Berlin and focusing on young, rapidly growing businesses.
Hennigsdorf-based Fiagon seeks to use Chinese capital to initiate operations in the Middle Kingdom, where there is a high level of interest in innovations “made in Brandenburg”.
DWG German Spine Meeting, Frankfurt: (10.-12.12.2015) – The German Fiagon AG, Henningsdorf/Berlin, a medical technology company that develops and manufactures innovative surgical navigation systems including flexible instruments and the German company joimax®GmbH, Karlsruhe, developer and manufacturer of technologies and training methods for minimally invasive endoscopic spinal surgery, announced their partnership today.
Berlin/Hennigsdorf Deloitte conferred the “Technology Fast 50 Awards” on Germany’s fastest growing technology companies at the Museum for Communication in Berlin on the evening of 2 November. Fiagon AG not only picked up the Special Award for Innovation, it also ranks 5th among Germany’s 50 fastest growing companies.
